Building on over a decade of neurovascular catheter development, the SOFIA™ 88 Neurovascular Support Catheter introduces a large 0.088-inch inner diameter paired with proprietary engineering enhancements. Optimized transition zones ensure reliable trackability through complex cerebral anatomy, while a soft, atraumatic distal tip minimizes vessel injury. This design innovation not only advances the SOFIA™ line’s proven performance but also offers physicians unprecedented control and flexibility during delicate thrombectomy procedures.

The SOFIA™ 88 integrates seamlessly into existing stroke intervention workflows, compatible with Terumo’s SOFIA™ Flow Plus 6F Aspiration Catheter and other key devices in the stroke portfolio. Whether used with short or long sheaths, its proximal stability supports both aspiration-only and combination approaches. Clinicians can confidently navigate challenging vessels, enhance first-pass recanalization rates, and reduce procedure times—critical factors in achieving better outcomes for patients experiencing acute ischemic stroke.

With stroke remaining a leading cause of disability and death worldwide, the commercial availability of the SOFIA™ 88 catheter in the U.S. marks a pivotal advancement in endovascular therapy. By combining large-bore support, atraumatic design, and proven clinical efficacy, Terumo Neuro empowers hospitals and stroke centers to deliver faster, safer, and more effective reperfusion treatments. This launch underscores the company’s commitment to driving meaningful improvements in stroke care and expanding access to cutting-edge neurovascular technologies.